Start with the research question.
Not a static data catalog.
Tamarin builds source-connected research capacity around the clinical populations researchers actually need.
Some areas already have participating organizations. Others are actively expanding in response to funded research and clinical trial demand.
Don’t see your research area? Tell us what you need. Tamarin can identify and onboard additional healthcare organizations for specific studies.
WOMEN’S & REPRODUCTIVE HEALTH
ACTIVE RESEARCH DEMAND
Tamarin is actively developing research access across women’s health, reproductive aging, and longitudinal hormonal and menstrual health.
Current areas of interest include:
Ovarian reserve, including AMH and AFC
Menstrual cycle history
Perimenopause and menopause
Hormonal health
Longitudinal reproductive aging
Model development and validation
Real-world evidence
Have relevant data?
We are currently adding healthcare organizations with longitudinal reproductive-health data for funded commercial research.
Need this population?
Tell us the variables and cohort you need and we’ll assess participating and potential healthcare organizations
FERTILITY & IVF
NETWORK DEVELOPING
Tamarin is working with fertility and IVF clinics interested in participating in both retrospective research and sponsored clinical studies.
Potential research applications include:
IVF treatment and cycle analysis
Ovarian stimulation research
Embryology and treatment outcomes
Model validation
Real-world evidence
Clinical trial feasibility
Site discovery
Patient recruitment
Prospective clinical research
From retrospective research to clinical trials
Because participating clinics remain connected to the data, the same network can potentially support both analysis and prospective study participation.
OPHTHALMOLOGY & GLAUCOMA
NETWORK DEVELOPING
Tamarin is building an ophthalmology research network designed to support both retrospective glaucoma research and prospective clinical trial applications.
Potential uses include:
External model validation
Disease progression research
Treatment-pattern analysis
Longitudinal outcomes
Protocol feasibility
Site identification
Patient recruitment
Prospective clinical studies
Go beyond de-identified retrospective data.
The same source-connected infrastructure can support retrospective analysis, model validation, trial feasibility, site identification, patient identification, and recruitment without requiring a new data integration for each use.
METABOLIC, HORMONE & WELLNESS
DATA PARTNERSHIP IN DEVELOPMENT
Tamarin is developing research opportunities across multi-location outpatient populations spanning metabolic care, hormone therapy, wellness treatments, and longitudinal patient encounters.
Potential research dimensions include:
Weight management
Treatment exposure and persistence
Hormone therapy
Symptom and questionnaire measures
Longitudinal treatment patterns
Patient utilization
Real-world evidence
Clinical trial feasibility
Site discovery
Potential study types include retrospective analysis, model validation, outcomes research, and prospective clinical research.
LOOKING FOR SOMETHING ELSE?
Bring us the study. We’ll help find the data.
Tamarin is not limited to the research areas above.
Researchers can bring us a population, variable set, model, or protocol. We work with existing partners and can source additional healthcare organizations when a study requires new clinical data.
Examples
“I need longitudinal women with AMH and menopause outcomes.”
“I need an independent glaucoma population to validate my model.”
“I need IVF clinics that could participate in a prospective study.”
“I need to know which sites have enough patients for this protocol.”
That demand helps determine where the Tamarin network expands next.
FOR HEALTHCARE ORGANIZATIONS
Have data researchers need?
Tamarin brings funded research opportunities to healthcare organizations without charging them to simply participate in the network.
Opportunities can include:
Paid retrospective analyses
Model-validation studies
Real-world evidence
Clinical trial feasibility
Sponsored clinical trials
You decide which opportunities your organization accepts.